20/20 Biolabs, Inc. (AIDX)
0.5139
-0.04
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
0.5139
0.00 (0.00%)
After-Hours: 20:00
20/20 Biolabs Profit Margin (Quarterly) : -206.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -206.2% |
| March 31, 2026 | -615.4% |
| December 31, 2025 | -243.0% |
| September 30, 2025 | -197.5% |
| March 31, 2025 | -138.1% |
| Date | Value |
|---|---|
| December 31, 2024 | -233.0% |
| September 30, 2024 | -519.0% |
| June 30, 2023 | -511.1% |
| March 31, 2023 | -475.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -1.46% |
| Intelligent Bio Solutions, Inc. | -341.9% |
| Anteris Technologies Global Corp. | -2.85K% |
| Quest Diagnostics, Inc. | 10.94% |
| Labcorp Holdings, Inc. | 8.02% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -387.3% |
| Return on Assets | -120.5% |
| Return on Invested Capital | -232.1% |
| Gross Profit Margin (Quarterly) | 41.71% |
| Operating Margin (Quarterly) | -170.3% |
| Return on Net Operating Assets | -391.8% |